Similar articles for PMID: 12900485

Year	Number of Results
2002	4
2003	3
2004	12
2005	8
2006	9
2007	6
2008	5
2009	4
2012	1
2024	0

1

CYPHER coronary stents and risk of thrombosis.

Choi SB. Choi SB. CMAJ. 2003 Aug 5;169(3):218. CMAJ. 2003. PMID: 12900485 Free PMC article. No abstract available.

2

Sirolimus-eluting stents: the novel application of basic science to coronary artery disease.

[No authors listed] [No authors listed] Ir Med J. 2002 Jul-Aug;95(7):196. Ir Med J. 2002. PMID: 12227523 No abstract available.

3

Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.

Kumar S, Suresh V, Prendergast BD, Brooks NH, Wicks P, Levy RD, Ray SG, Bennett DH, Lee HS. Kumar S, et al. Catheter Cardiovasc Interv. 2006 Nov;68(5):663-8. doi: 10.1002/ccd.20741. Catheter Cardiovasc Interv. 2006. PMID: 17034063

4

Sirolimus-eluting coronary stents.

Drenth DJ, Zijlstra F, Boonstra PW. Drenth DJ, et al. N Engl J Med. 2004 Jan 22;350(4):413-4; author reply 413-4. N Engl J Med. 2004. PMID: 14743520 No abstract available.

5

Vascular brachytherapy versus sirolimus eluting stents for the treatment of in-stent restenosis: a prospective registry.

Goy JJ, Urban P, Seydoux C, Couke P, De Benedetti E, Stauffer JC. Goy JJ, et al. Heart. 2004 Dec;90(12):1491-2. doi: 10.1136/hrt.2004.034413. Heart. 2004. PMID: 15547043 Free PMC article. No abstract available.

6

Sirolimus for the prevention of in-stent restenosis in a coronary artery.

Marks AR. Marks AR. N Engl J Med. 2003 Oct 2;349(14):1307-9. doi: 10.1056/NEJMp038141. N Engl J Med. 2003. PMID: 14523135 No abstract available.

7

Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.

Fineschi M, Gori T, Pierli C, Casini S, Sinicropi G, Buti A, Del Pasqua A, Bravi A. Fineschi M, et al. Can J Cardiol. 2005 Dec;21(14):1281-5. Can J Cardiol. 2005. PMID: 16341297

8

Drug coating improves stent performance.

[No authors listed] [No authors listed] Health News. 2002 May;8(5):5-6. Health News. 2002. PMID: 12132409 No abstract available.

9

[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].

Zahn R, Hamm CW, Zeymer U, Schneider S, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Schöbel WA, Sabin G, Senges J; deutsche Cyper-Register. Zahn R, et al. Herz. 2004 Mar;29(2):181-6. doi: 10.1007/s00059-004-2560-x. Herz. 2004. PMID: 15057439 German.

10

Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A; LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators. Mehilli J, et al. J Am Coll Cardiol. 2009 May 12;53(19):1760-8. doi: 10.1016/j.jacc.2009.01.035. J Am Coll Cardiol. 2009. PMID: 19422982 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year